Cargando…
Harnessing the IL-21-BATF Pathway in the CD8(+) T Cell Anti-Tumor Response
SIMPLE SUMMARY: In cancer, CD8(+) T cells enter a state of dysfunction within the tumor that prevents them from targeting and killing tumor cells. Our study aims to uncover how CD8(+) T cells can be helped by CD4(+) T cells or modified in order to improve their effector function against cancer. Thus...
Autores principales: | Topchyan, Paytsar, Xin, Gang, Chen, Yao, Zheng, Shikan, Burns, Robert, Shen, Jian, Kasmani, Moujtaba Y., Kudek, Matthew, Yang, Na, Cui, Weiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998696/ https://www.ncbi.nlm.nih.gov/pubmed/33809259 http://dx.doi.org/10.3390/cancers13061263 |
Ejemplares similares
-
Single-Cell Transcriptomics Reveals Core Regulatory Programs That Determine the Heterogeneity of Circulating and Tissue-Resident Memory CD8(+) T Cells
por: Chen, Yao, et al.
Publicado: (2021) -
Spatial transcriptomics demonstrates the role of CD4 T cells in effector CD8 T cell differentiation during chronic viral infection
por: Topchyan, Paytsar, et al.
Publicado: (2022) -
Group 3 innate lymphoid cells require BATF to regulate gut homeostasis in mice
por: Wu, Xiaopeng, et al.
Publicado: (2022) -
BATF is Required for Treg Homeostasis and Stability to Prevent Autoimmune Pathology
por: Khatun, Achia, et al.
Publicado: (2023) -
The Role of CD4 T Cell Help in CD8 T Cell Differentiation and Function During Chronic Infection and Cancer
por: Topchyan, Paytsar, et al.
Publicado: (2023)